The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

Pirouette aims to use their patented technology to revolutionize the $600B injectable medicine market, making life-saving injections as easy as pushing a button PORTSMOUTH, N.H.–(BUSINESS WIRE)–May 7, ...

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, ...

(RTTNews) - Ypsomed Holding AG (YPHDF) announced Monday that its digital connectivity add-on, SmartPilot, has received 510(k) clearance from the U.S. Food and Drug Administration or FDA. SmartPilot ...

DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...

An announcement from Embecta Corporation ( (EMBC)) is now available. On May 15, 2026, Embecta completed its acquisition of Owen Mumford Holdings Limited, following a March 19, 2026 purchase agreement ...

Kaléo, a global leader in drug-device technology and auto-injector innovation, is sponsoring premiere events for May Contain, during Asthma & Allergy Awareness Month. The award-winning docudrama film ...

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Pirouette, with their innovative auto-injector platform, announced they have surpassed $5M raised in their community investment round on Wefunder, prompting them to ...